about
Management of mild hypertension. Selecting an antihypertensive regimen.Diuretic induced changes in symptoms and quality of life.Towards measurement of outcome for patients with varicose veins.The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study GroupABC of Dermatology. Psoriasis.Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.Consumer collaboration, patient-defined outcomes and the preparation of Cochrane Reviews.Patients' responses to risk information about the benefits of treating hypertension.The Lilly Prize lecture. University of London, December 1986. On assuring pharmacotherapeutic progress in the 21st century.Quality-of-life measurements: origin and pathogenesis.Dietary sodium restriction for mild hypertension in general practiceQuality of life with macular degeneration: perceptions of patients, clinicians, and community members.Salt restriction for borderline hypertension.Sexual problems and their management: a survey of general practice in Northern Ireland.Pictures of the patient: medicine, science and humanitiesPatient expectations and health-related quality of lifeEssential hypertension: a sign in search of a disease.Assessment of quality of life in the treatment of hypertension.Cancer chemotherapy and quality of life.Hypertension and wellbeing.Psychological effects of nicardipine and propranolol on hypertensive patients.
P2860
Q33558825-4DC1C020-75C6-4C95-B2A9-25B702128AD8Q33614253-B5B52FE5-A58D-4191-909E-A6B15DFBA806Q33691142-8D97D8CE-3321-46FE-8864-CC21498D842FQ34029556-271B9A57-5B21-4316-8F87-C0F37D0F39DCQ34072639-41B848FD-AAC9-4923-BFDB-285B7BE0C2FAQ34163705-92BF8F27-DA8E-463E-8345-034F2DD8233CQ34204495-BE7020E6-D681-4B04-8351-70077F269654Q34220002-74DA676D-A91D-4E41-9888-97D3B8CC7BF4Q34416530-DFA6BC3D-826A-466D-AABB-325C8EF466B7Q34852030-33432283-4803-4504-834C-E3EE2CD239B8Q34990694-E3238CF0-9EF6-4A25-85CD-9622CBC13CA6Q35590440-2BC2B7AB-169F-4B11-B993-D796BE5C8AD2Q35963514-4C27D096-D913-4BD7-BA70-966FDEEA3466Q36750593-56D76F4E-D690-4C17-BC83-F30A64003B3CQ36920931-296FF231-9C28-4BD2-8E64-BE6285CCD0D2Q37334350-8251501B-AF5B-47F1-BD54-15B02F5AE64DQ41513373-8B287A2B-5303-4920-9522-99116FC20AF5Q41862690-F216A123-4CA2-45DC-A04B-AB9FFE1F1289Q42763992-91245697-CAB2-4A1C-B923-071882332B78Q42864745-BBB785EB-DE0E-475A-A26D-B56FA984CE1EQ46529757-E5693C85-DACD-4A09-B929-CA9F9FA54FD8
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
The effect of hypotensive drugs on the quality of life.
@ast
The effect of hypotensive drugs on the quality of life.
@en
type
label
The effect of hypotensive drugs on the quality of life.
@ast
The effect of hypotensive drugs on the quality of life.
@en
prefLabel
The effect of hypotensive drugs on the quality of life.
@ast
The effect of hypotensive drugs on the quality of life.
@en
P2093
P2860
P1476
The effect of hypotensive drugs on the quality of life
@en
P2093
Brierley H
Jachuck SJ
Willcox PM
P2860
P304
P577
1982-02-01T00:00:00Z